Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer
Clinical and Experimental Pharmacology and Physiology · 2026-11 · 53 (11)
DOI: 10.1111/1440-1681.70158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 08.11.2026. Verfasst von Xinxing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, Tongji University, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Objective
This study aimed to investigate the expression pattern, clinical significance, immune association and biological function of general control nonderepressible 1 (GCN1) in colorectal cancer (CRC).
Methods
Gene expression and clinical data from 1603 CRC patients were obtained from TCGA and E‐MTAB‐12862 datasets, with external validation using GEO cohorts. Tumour immune cell proportions were estimated using the CIBERSORT and ESTIMATE algorithms. Predicted drug responses were assessed using the oncoPredict package based on the GDSC database. In vitro functional experiments, including MTT proliferation assays and transwell migration and invasion assays, were conducted in HCT116 and HT29 cell lines following GCN1 knockdown.
Results
GCN1 was significantly upregulated in CRC tissues compared with normal tissues. Higher GCN1 expression was associated with improved overall survival in early‐stage CRC and lower tumour stage. Immune microenvironment analysis revealed that tumours with high GCN1 expression showed computationally inferred enrichment of antitumor immune cell populations and reduced immunosuppressive components, along with lower TIDE scores. Functional enrichment analyses indicated that GCN1 was involved in pathways related to cell cycle regulation, DNA replication and epithelial–mesenchymal transition (EMT). Knockdown of GCN1 significantly inhibited CRC cell proliferation, migration and invasion while modulating EMT and cell cycle‐related proteins. Drug sensitivity prediction further indicated that tumours with high GCN1 expression exhibited lower computationally inferred IC50 values for several commonly used chemotherapeutic agents, including 5‐fluorouracil, oxaliplatin, paclitaxel and docetaxel.
Conclusion
Our findings suggest that GCN1 may exhibit context‐dependent associations in CRC. While in vitro experiments support a tumour cell‐intrinsic role of GCN1 in regulating malignant phenotypes through EMT‐ and cell cycle‐related processes, higher GCN1 expression at the tissue level was also associated with favourable clinical and immune‐related features. These observations suggest that GCN1 may serve as a potential prognostic indicator and warrant further mechanistic investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Biomedical Research Center, Monrovia, California, USA.
- Proteomics Division, Mochtar Riady Institute for Nanotechnology, Universitas Pelita Harapan, Tangerang, Banten, Indonesia.
- Department of Biology, Universitas Pelita Harapan, Tangerang, Banten, Indonesia.
ORCID-Profile: Xinxing Li, Lin Zhu, Zhiqian Hu, Ariela Samantha, Io Nam Wong, Xinxiang Li
Förderung
- Science and Technology Commission of Shanghai Municipality
- Tongji University
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
- Shanghai Municipal Health Commission
- Shanghai Tongji Hospital (Tongji Hospital Affiliated to Tongji University)
- Macao Science and Technology Development Fund
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
Zitieren
APA
Li, X., Yang, X., Zhu, L., Weng, J., Shan, Z., Hu, Z., Samantha, A., Wong, I. N., & Li, X. (2026). Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer. Clinical and Experimental Pharmacology and Physiology, 53(11). https://doi.org/10.1111/1440-1681.70158
Vancouver
Li X, Yang X, Zhu L, Weng J, Shan Z, Hu Z, et al. Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer. Clinical and Experimental Pharmacology and Physiology. 2026;53(11). doi:10.1111/1440-1681.70158
BibTeX
@article{Li2026,
author = {Li, Xinxing and Yang, Xin and Zhu, Lin and Weng, Junyong and Shan, Zezhi and Hu, Zhiqian and Samantha, Ariela and Wong, Io Nam and Li, Xinxiang},
title = {Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2026},
volume = {53},
number = {11},
doi = {10.1111/1440-1681.70158}
}
EUVIMED